We have had success with every indication we have tried, and we look forward to future studies with them.
Costa Mesa, California (PRWEB) December 19, 2016
Centex Studies, Inc. has recently chosen StudyKIK, a clinical trial patient recruitment company that specializes in connecting quality patient groups through social media communities to clinical research sites, as their preferred recruitment provider. In response to a steady increase in ongoing studies, Centex Studies decided to implement this selection immediately.
“StudyKIK is Centex Studies' preferred method of patient recruitment because they always send a good amount of qualified patients that are actually interested in participating in the trial. We have had success with every indication we have tried, and we look forward to future studies with them,” said Machelle Roberts of Centex Studies, Inc.
Centex Studies, Inc. provides specialty services for doctors, pharmaceutical companies and patients, while supporting clinical trials in various therapeutic areas. Now, as their preferred recruitment provider, StudyKIK will gain access to ongoing clinical trials per year run by Centex Studies, Inc. Through this new partnership, StudyKIK will use their network of resources to help bring patients to Centex Studies, Inc.’s various research sites.
“Having Centex Studies Inc. select StudyKIK as their Preferred Recruitment Provider for 2017 is very exciting because we see them as a powerhouse for clinical trial enrollment and study execution. This forward thinking organization will continue to provide study sponsors clinical trial recruitment excellence and StudyKIK is excited to be part of that," stated Matt Miller, Vice President of Global Patient Recruitment and Feasibility.
StudyKIK continues to focus on expanding the awareness of clinical trials globally while providing research sites with as many tools as possible to enroll clinical trial volunteers. To learn more about StudyKIK, visit StudyKIK.com.
To learn more about Centex Studies, Inc., visit http://centexstudies.com